Video Experimental Relacionado
Updated: Feb 22, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
49.5K
Moduladores del receptor TRPV1: Terapias emergentes para el dolor neuropático, osteoartrítico y perioperatorio
1Department of Anesthesiology and Perioperative Medicine, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
CNS drugs
|February 21, 2026
Resumen
Los canales de vanilloide potencial receptor transitorio 1 (TRPV1) son objetivos complejos de fármacos para el alivio del dolor. La investigación está avanzando, mostrando promesas para nuevos fármacos agonistas y antagonistas de TRPV1 en desarrollo clínico para diversas condiciones de dolor.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Farmacología Farmacología.
Sus antecedentes:
- La capsaicina es un conocido analgésico que se dirige a los canales del receptor transitorio potencial de vanilloide 1 (TRPV1).
- Los canales TRPV1 son objetivos complejos y multifuncionales involucrados en la nocicepción, la termorregulación y las respuestas ambientales, lo que dificulta la orientación terapéutica debido a los posibles efectos secundarios.
Objetivo del estudio:
- Revisar los desafíos y el progreso en el desarrollo de agentes terapéuticos dirigidos al TRPV1 para el control del dolor.
- Para resaltar prometedores candidatos a fármacos agonistas y antagonistas actualmente bajo investigación.
Principales métodos:
- Revisión de la literatura existente sobre la función del canal TRPV1 y el desarrollo de fármacos.
- Identificación y categorización de compuestos potenciales agonistas y antagonistas del TRPV1.
Principales resultados:
- El desarrollo de agentes dirigidos al TRPV1 ha sido lento debido a la complejidad del receptor.
- Varios agonistas farmacéuticos prometedores (por ejemplo, formulaciones de capsaicina, resiniferatoxina, CNTX-4975, vocacapsaicina) y antagonistas (por ejemplo, NEO6860, Mavatrep, ACD-440) están en desarrollo.
- El aumento de la comprensión de los canales TRPV1 está llevando a desarrollos clínicos positivos.
Conclusiones:
- Los canales TRPV1 siguen siendo un objetivo desafiante pero significativo para la terapia del dolor.
- La investigación en curso y la comprensión estructural en evolución están allanando el camino para nuevos medicamentos basados en TRPV1.
- Los desarrollos clínicos son prometedores para el tratamiento del dolor neuropático, musculoesquelético, postoperatorio y del cáncer.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:25Analgesia and Pain Management
2.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.2K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
01:22Opioid Receptors: Overview
5.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.1K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
1.2K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.2K
01:20Pain
1.5K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.5K
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
1.6K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.6K